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Abstract
In this paper, we developed an approach for detecting brain regions that con-
tribute to Alzheimer’s Disease (AD) using Support Vector Machine (SVM)
classifiers and the recently developed Self Regulating Particle Swarm Op-
timization (SRPSO) algorithm. SRPSO employs strategies inspired by the
principles of learning in humans to achieve faster and better optimization
results. The classifiers for distinguishing subjects into AD patients and Cog-
nitively Normal (CN) individuals were built using Grey Matter (GM) and
White Matter (WM) volumetric features extracted from structural Magnetic
Resonance (MR) images. It could be observed from results that the clas-
sifier built using both GM and WM features provided accuracy of 89.26%
which is better than the performance of classifier built using either GM or
WM features only. Moreover, consideration of clinical features in addition to
volumetric features improves the accuracy of the classifier further to 94.63%
which is better than the performance reported by recent works in literature.
In order to identify the brain regions that are important for AD vs CN classi-
fication problem, we used SRPSO to extract GM and WM features that are
important for better classification performance. This helped in reducing the
number of features by a factor of hundred. After evaluation, accuracy ob-
tained by 50 feature selected through SRPSO was 89.39% which was slightly
more than the accuracy reported by combined GM and WM features.The
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features identified by SRPSO were also mapped back to the brain using Au-
tomatic Anatomic Labelling (AAL) template to identify brain regions that
exhibit degeneration in AD. In addition to identifying areas known to be
involved in AD like cerebellum, hippocampus, this helped in finding newer
areas that might contribute towards AD.
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1. Introduction
Alzheimer’s Disease (AD) is the most commonly occurring cause of de-
mentia as per a recent study by the World Health Organization. It causes
neurodegeneration which leads to cognitive and memory impairments. The
number of people suffering from AD worldwide were reported to be 33.9 mil-
lion in 2011 which is likely to triple by 20501. This makes early and accurate
diagnosis of AD an important problem as clinical symptoms of AD become
apparent only after a significant amount of brain tissue has already been
damaged. Magnetic Resonance Imaging (MRI) has strongly contributed to
progress in this direction. Its high spatial resolution as well as sensitivity to
brain’s shape and volume2 allows it to capture structural atrophy in early
stages of AD. Furthermore, MRI techniques do not employ any radioactive
or radiation-emitting substances which makes it safer for repetitive use in
tracking development of the disease.
Several MRI-based approaches have been developed for automatic clas-
sification of subjects into AD patients or Cognitive Normal (CN) subjects.
Broadly, these approaches can be divided into two categories: methods that
use information from specific Regions Of Interest (RoI) and methods that
employ voxelwise features obtained from whole brain MRI data. RoI based
methods focus on structures in the brain that are known to be involved
in AD3–5. The involvement of hippocampus in AD is well-known and has
been the motivation for many computational studies that focused on this
problem3,6,7. Similarly, many studies have also developed models based on
features extracted from other brain areas like amygdala8, entorhinal cortex3,
cerebellum9, frontal lobe10, temporal lobe11 etc. A limitation of RoI-based
methods is that their performance depends on experimenter’s expertise in se-
lecting appropriate RoIs. Further, they do not provide any information about
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the contribution of those regions towards the disease that are excluded from
analysis.
The performance of methods that utilize whole brain voxels do not rely
on an expert for selection of RoIs as all voxels are considered in the analysis.
This has encouraged many researchers to develop whole brain MRI-based
methods for distinguishing AD patients from CN subjects12,13,15. One of
the first studies in this direction demonstrated that a Support Vector Ma-
chine (SVM) trained using whole brain MRI data for the problem of AD
vs CN classification performed better than a trained radiologist16. Further,
Cuingnet et. al.15 also showed that methods based on whole brain voxels
have higher sensitivity and specificity than methods which employ features
extracted from specific RoIs.
Most existing studies have only employed Grey Matter (GM) features ex-
tracted from MRI data for the problem of AD vs. CN classification. However,
there is ample evidence that suggests existence of a pathological relationship
between GM and White Matter (WM) atrophy17–22 indicating that WM de-
generation might be a powerful biomarker for detecting the progression of
AD. Existing studies in this direction have mostly looked at data collected
using Diffusion Tensor Imaging (DTI)23,24. Dybra et. al.23 developed na¨ıve
bayes and SVM classifiers for the problem of AD vs CN classification using
estimates of structural disconnection in WM regions. Haller et. al.24 de-
veloped a SVM classifier for distinguishing between patients with different
subtypes of Mild Cognitive Impairment (MCI) based on features extracted
from WM regions. It has been shown using MRI data that WM regions in AD
subjects show non-ageing related degradation25 but this has not been suffi-
ciently exploited by computational models for automatically distinguishing
AD patients and CN individuals.
Furthermore, whole brain voxel-based methods have the potential to au-
tomatically identify brain areas that contribute towards AD. This is generally
described as a feature selection problem where the aim is to identify a smaller
distinct set of features that are sufficient to accomplish a given task. For the
problem of distinguishing AD patients from CN subjects using structural
MRI data, this corresponds to identifying a small number of voxels that are
important for the classification problem. A feature selection approach was
developed by Mahanand et. al.26 using a self-adaptive resource allocation
network and Integer-coded Genetic Algorithm using voxel-based features ex-
tracted from GM regions. Similarly Chyzhyk et. al.27 used evolutionary
wrapper feature selection mechanism using genetic algorithm for training ex-
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treme learning machines on selected cluster of features. In an alternative
approach, Mishra et. al.14 ranked brain regions as per their impact dur-
ing progression of disease which helped identify those brain regions that are
affected by the onset of the disease.
Motivated by results highlighting WM degeneration in AD patients, in
this paper, we studied the impact of various clinical attributes and features
extracted from MRI data on the performance of SVM for the AD vs CN
classification problem. For this purpose, three different SVM classifiers were
build using features extracted from GM regions, WM regions and a com-
bination of GM and WM regions. The performance of all classifiers were
obtained using 10-fold cross validation. A performance comparison of the
classifiers showed that classifiers built using both GM and WM features per-
formed better than classifiers built only using either GM or WM features.
Further, consideration of clinical features like Mini Mental State Examina-
tion (MMSE) and Clinical Dementia Rating (CDR) along with GM and WM
features resulted in further improvements in the classification accuracy. In
addition, using these classifiers as a basis, a method was developed for iden-
tifying the brain regions that exhibited different characteristics in AD and
CN subjects. This method uses the recently developed Self Regulating Parti-
cle Swarm Optimization (SRPSO)28 to select a small subset of features that
are important for obtaining good classification performance. Based on the
use of these techniques, the method has been named SRPSO-SVM classifier.
SRPSO was originally developed for an optimization problem with continu-
ous variables. Here, it was extended to discrete optimization problems for
selection of voxels that provide information useful for the classification prob-
lem. The features selected using the SRPSO-SVM classifier could possibly
help in identifying the brain regions that exhibit differential atrophy across
AD and CN subjects.
For evaluating the performance of SRPSO-SVM classifier, we used it to
select 10, 20, 30, 40 and 50 features that are useful for higher classification
performance. SRPSO-SVM was used in two different scenarios, namely selec-
tion of features from GM regions and feature selection based on combination
of GM and WM regions. Based on the features selected by the SRPSO-SVM
classifier, the performance of SVM classifier was computed using 10-fold cross
validation for each scenario. For the different number of features selected, the
SRPSO-SVM classifier constructed using GM and WM features performed
better than the classifier build using GM features alone. This also estab-
lishes the importance of WM features in developing automated models for
4
distinguishing AD and CN subjects. Following identification of features, Au-
tomatic Anatomic Labelling (AAL) template was used to map the selected
features to the brain region from where they were recorded. This enabled
us to identify the brain regions that exhibited different properties in normal
and AD subjects. It was observed that features derived from cerebellum and
hippocampus were selected most often by the SRPSO-SVM classifier which
is in line with clinical studies involving AD subjects9,29. Other brain regions
selected by the SRPSO-SVM classifier that have also been implicated in clin-
ical studies include frontal lobe30, temporal lobe31, occipital lobe with cal-
carine fissure32, cingulate cortex33, amygdala34, praecuneus35 and parietal
lobe36, supplementary motor area37, postcentral gyrus35, fusiform gyrus38
and para-hippocampus gyrus26, etc. Besides, those indicated above, several
other regions were also detected by the SRPSO-SVM classifier which might
provide information about other brain regions that are involved in AD but
have not yet been clinically identified.
The rest of the paper is organised as follows: section 2 gives details about
dataset and its distribution in training and testing sets. Also, data prepro-
cessing is described in section 2. Section 3 provides mathematical modelling
of SVM as a classifier and SRPSO as a feature selection technique. Section 4
offers experimental setup details and results followed by concluding remarks
in section 5.
2. Materials and methods
2.1. Participants and data
The standard dataset used is this study was obtained from the Alzheimer’s
Disease Neuroimaging Initiative (ADNI) (adni.loni.usc.edu). A total of 299
participants were considered which consists of 137 AD patients (67 male and
70 female) and 162 (76 male and 86 female) controls aged between 55 years
and 91 years. The collection of subjects used in this study is same as that
used in15. Standard 1.5T MR images from baseline or screening visits were
used and similar demographics (gender and age) were maintained in training
and testing dataset. All images were subjected to same correction procedures
post acquisition for removal of imaging artifacts. These correction procedures
included 3D gradwarp correction, B1 non-uniformity correction and N3 bias
field correction. The clinical scores for the subjects were also considered in
the analysis. CN subjects had MMSE scores between 24 and 30 and CDR
score equal to zero. Similarly, AD subjects had MMSE scores between 20
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and 26 and CDR score of either 0.5 or 1. For the purpose of classification
MMSE and CDR scores for all subjects were normalized to the interval [0,1].
A summarized description of the data used in this study is provided in table
1.
[insert table 1]
2.2. Data Preprocessing
All T1 weighted images were preprocessed using Statistical Parametric
Mapping Toolbox 12 (SPM12) in MATLAB 9.0. Figure 1 shows a schematic
description of different steps involved in preprocessing. Each MR images was
segmented into GM, WM and Cerebrospinal Fluid (CSF) tissue probability
maps using the unified segmentation algorithm39. The unified segmentation
algorithm employs a mixture of Gaussians to build a probabilistic generative
model of the data. The voxel-wise tissue probability maps obtained from the
model are combined using a Bayesian formulation. After segmentation, all
images were registered to a custom template which was iteratively generated
using the DARTEL toolbox40. In each iteration, the toolbox computes a
deformation from the template to each image and an inverse of the deforma-
tion is applied to the images. These transformed images are then averaged to
compute a new template. All images registered to the final template obtained
using DARTEL were normalized with respect to the Montreal Neurological
T1 (MNI152) template. The normalized images were smoothed using a 10-
mm full-width at half-maximum isotropic Gaussian kernel. Each smoothed
image is then modulated with the Jacobian determinant of its deformation
field. These preprocessing steps resulted in 2122945 features for each image.
To reduce the dimensionality of the feature space, the obtained images were
resampled using a 6mm wide isotropic Gaussian kernel. This resulted in
35557 features. To discard artefacts like background and air, a brain mask
was applied to each resampled images. This preprocessing procedure finally
resulted in GM and WM tissue probability maps each of which consisted of
8729 features.
For calculation of Hippocampal Volume (HV), a hippocampus mask was
extracted from standard AAL atlas using WFU PickAtlas 3.0 toolbox52–54.
The resolution of generated mask was manipulated to match the prepro-
cessed dataset. The resultant binary mask was then applied to GM tissue
density maps obtained after MNI normalization. This resulted in 1878 voxels
extracted only from hippocampus regions of left and right hemisphere. The
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HV was calculated for each subject by summing the intensity of the voxels
contained by this mask as described in51.
[insert figure 1]
3. SRPSO-SVM Classifier for Feature Selection
The problem of feature selection for AD focuses on identifying the features
that contribute towards improving the classification performance. By map-
ping a given selected feature back to the voxel from which it was extracted,
it is possible to identify the specific brain region that exhibits different struc-
tural properties between AD subjects and normal individuals. This might
help in finding brain regions that show degradation in AD. In order to identify
such brain areas, we describe below a feature selection approach that utilizes
SRPSO and SVM and hence has been named the SRPSO-SVM classifier. To
provide the necessary background, this section begins with a description of
SVM and SRPSO. Using this background, the problem of feature selection
utilizing the SRPSO-SVM classifier will be formulated.
3.1. Support Vector Machines
Support vector machine (SVM) is a supervised learning approach that has
been used for a wide range of problems in machine learning. In this study, a
SVM classifier for two classes was built using samples (x1, y1), . . . , (xi, yi), . . .
where xi ∈ Rp represents a sample from class yi ∈ −1,+1. A standard SVM
classifier estimates the parameters ω and b which describe a hyperplane that
separates samples from the two classes. This is referred as a hard margin
SVM. However, hard margin SVM is limited to problems where samples from
the two classes are linearly separable. For linearly inseparable problems, soft
margin SVM was developed which relaxes the constraints imposed by a hard
margin SVM. A soft margin SVM estimates a hyperplane that minimizes the
following objective function:
ω∗, b∗, ζ∗ = arg min
ω,b,ζ
1
2
‖ ω ‖2 +C
m∑
i=1
ζi
where yi(ω
Txi + b) ≥ 1− ζi, ∀ i = 1, . . . ,m, (1)
ζi ≥ 0, ∀ i = 1, . . . ,m.
In the above equation, parameter C determines the penalty of misclassifi-
cation error which is represented by ζi. In our work, value of parameter C
remain 1 throughout the experiments.
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3.2. Self Regulating Particle Swarm Optimization
The original Particle Swarm Optimization(PSO)41 algorithm is inspired
by social behaviour of animals in a group such as a flock of birds, school
of fish, etc. It involves simulating a swarm of particles whose positions are
given by a D-dimensional vector in the search space. The position of the ith
particle in the tth iterations given by xti = [x
t
i1, x
t
i2, . . . , x
t
iD] which denotes
a candidate solution and its velocity in the tth iteration is denoted by vti =
[vti1, v
t
i2, . . . , v
t
iD]. To search for optimal solutions, particles move around in
the search space by updating their velocity using experience acquired by all
particles in the swarm. The best position explored by the ith particle is
denoted by P ti and best position explored by the whole swarm is denoted
by P tg . In each iteration, the velocity of the i
th particle is calculated by
considering its personal best position and the global best position of the
swarm using the following equation
vt+1i = v
t
i + c1r1(P
t
i − xti) + c2r2(P ti P tg − xti) (2)
where c1 and c2 represent the acceleration coefficients and r1 and r2 are
the random numbers distributed uniformly in the range [0,1]. Based on the
computed velocity, the position of the ith particle in (t+1)th iteration is given
by
xt+1i = x
t
i + v
t+1
i (3)
Similar to original PSO algorithm , SRPSO is an iterative evolution-
ary technique that explores the search space for prospective solutions to
a given problem. In addition to the experience of particles in the swarm,
SRPSO incorporates in each particle the ability to adapt its velocity based
on two strategies grounded in human cognitive psychology. These strate-
gies include self-regulating the inertia weight and self-perception of search
directions. The first strategy updates the inertia weights (ωi) for the best
particle and other particles using different update rules to achieve faster ex-
ploration of the search space. The second strategy emphasizes collaborative
exploration among particles in SRPSO. Next, the two strategies of SRPSO
are described in detail.
• Self-regulating the inertia weight: The parameter inertia weight
(ωi) in SRPSO determines the balance between exploration and ex-
ploitation performed by the particles. Original PSO employed a ’com-
mon’ inertia weight for all particles which is decreased linearly whereas
8
in SRPSO each particle had an individual inertia weight which is up-
dated using a self-regulating inertia weight strategy. In this strategy,
the particle that achieved the current global optimum increases its in-
ertia weight in a given iteration whereas all other particles decrease
their inertia weight. This encourages the particle that achieves current
global optimum to perform exploitation by accelerating in its current
direction of search. Thus, inertial weight of the ith particle is updated
using the following equation in this strategy:
ωi(t+ 1) =
{
ωi(t) + η∆ω, for best paricle,
ωi(t)−∆ω, otherwise
(4)
where η is a constant to control the rate of acceleration which is set to
1. ∆ω in inertia weight is computed as follows:
∆ω =
ω1 − ωF
Niter
=
0.55
Niter
, (5)
where ωI and ωF are initial and final values of inertia weight, respec-
tively. NIter is the total number of iterations.
• Self-perception of search directions: Unlike PSO, in SRPSO, the
best particle and other particles have different velocity update mecha-
nisms. Each particle other than the best particle considers its percep-
tion of the search direction of other particles to adjust its own velocity.
This is referred as social cognition in SRPSO. Based on this, the gen-
eral velocity update equation in SRPSO for a particle having is given
by:
vt+1i = ωiv
t
i + c1r1p
se
i (P
t
i − xti) + c2r2psoi (P tg − xti), (6)
Where psei represent the parameter that determines perception for the
self-cognition and psoi determines perception for the social cognition.
The best particle gives priority to its current search direction over its
self and social knowledge. Hence, the value of psei and p
so
i are set to
zero for the best particle. For rest of the particles, psei is set to 1.
Social cognition is realized in SRPSO in randomly selected iterations.
For this purpose, in each iteration a random number, denoted by a, is
generated in the range [0,1]. If a is greater then a threshold λ then psoi
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is set to 1, otherwise psei is set to zero. As stated in
28, λ was set to 0.5
for all experiments. A higher value of λ low social cognition in which
case particles do not pay attention to global best. A lower value of λ
resulted in excessive social cognition leading to premature convergence
to current global best. Based on this strategy, the velocity for best
particle is updated as
vt+1i = ωiv
t
i , (7)
and for rest of particles velocity is updated as
vt+1i = ωiv
t+1
i + c1r1(P
t
i − xti) + c2r2psoi (P tg − xti). (8)
Based on the updated velocity, the new position of the ith particle at
time (t+ 1) is computed as
xt+1i = x
t
i + v
t+1
i (9)
[insert table 2]
3.3. Features Selection
Several PSO-based feature selection approaches have been developed in
literature that rely on a particular classifier to get an estimate about the
optimality of a solution that a given particle represents42. Each solution rep-
resents a collection of features selected by the particle. An estimate of fitness
for a particular solution is determined using the performance of the classifier
which is built only using features that are selected in that solution. The
SRPSO-SVM classifier uses SRPSO to explore the search space for solutions
and the performance of SVM is used to obtain an estimate for the fitness of
a solution.
To select M features, the position of each particle is initialized using an
M -dimensional vector and each element in the vector is randomly initialized
to a value in the interval [1, Nf ] where Nf is the total number of features.
The position of a given particle represents the collection of features selected
by that particle. For each particle, a SVM classifier is built using the selected
features for the problem of AD vs CN classification . The fitness (ηi) of the
ith particle is estimated using the classification accuracy, given as
ηi =
Number of correctly classified samples
Total number of samples
× 100 (10)
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Based on the estimate of fitness, the position of the particles are updated
using the equation (9). It might be noted that the updated position of the
particle may contain non-integer values. To map these non-integer values
to a unique feature, these values were rounded to the nearest integer. This
procedure was repeated for 1000 of iterations in SRPSO. Pseudocode for
feature selection using SRPSO-SVM classifier is given in algorithm 1.
Algorithm 1 Pseudocode for SRPSO-SVM classifier.
1: Input: Training and testing samples, class information.
2: Initialize SRPSO parameters, n-number of selected features.
3: Initiate M number of selected features.
4: Call SRPSO function for optimization.
5: for each iterations do
6: Evaluate fitness (SVM classification performance; equation (10)) for
each particle.
7: Regulate inertia weight for each particle based on its fitness.
8: Update particle’s best and global best.
9: end for
4. Results and discussion
In this section, we present results of the four different studies that are used
to evaluate the effectiveness of the approach presented here. An initial study
is conducted to understand the usefulness of GM and WM features for AD
vs. CN classification problem using SVM classifiers. In addition, this study
also assesses the effectiveness of HV and clinical features for this classification
problem. The clinical features consist of classwise scores of MMSE and CDR
tests of each subject, which were normalized in the interval [0,1], prior to their
use in classification. In the next study, the performance of the SVM classifier
for AD vs CN problem using different combination of features was compared
with the performance reported in recent works in literature. Subsequently,
an evaluation of the SRPSO-SVM classifier for feature selection is done using
volumetric features (GM and WM) subsets of various sizes. Thereafter, the
features selected by the SRPSO-SVM classifier are mapped to specific brain
areas from where they were extracted to identify areas that are important
for better AD vs. CN classification.
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All results reported in this section have been obtained using the train-
ing/testing splits mentioned in Table 1. Each sample was subjected to the
pre-processing steps described in Section 2. After pre-processing, 8729 fea-
tures were obtained from both GM and WM regions resulting in a total of
17458 features. It is known that WM and GM matter legions show different
pattern of degradation43. To avoid issues arising because of these differences,
features obtained from both GM and WM regions were normalized to the in-
terval [0,1]. The performance evaluation was conducted using sensitivity,
specificity, accuracy, precision and F1 score.
All the experiments described in this paper were conducted on a machine
having an Intel core i5 processor with processing speed of 2.50 GHz CPU
and 8 GB of RAM. The implementations for experiments were written using
Python 3.7 and executed on a machine with Ubuntu v18.04
4.1. Performance Comparison using volumetric and clinical features
In this section, the performance of the SVM classifier for the AD vs CN
problem was evaluated using ten different combinations of features extracted
from the MRI data. These scenarios include performance evaluation using
features extracted from GM regions, WM regions and a combination of GM
and WM regions. The scenario that includes features obtained from both
GM and WM regions will be concisely referred as (GM+WM). Other sce-
narios included consideration of clinical scores (MMSE and CDR) and HV
in addition to the volumetric features.
The training/testing results of the classifier were obtained using the same
splits in all the scenarios described above. Table 3 presents the classification
accuracy, sensitivity, specificity, F1 Score, and precision. It can be observed
from table 3 that the GM feature based classifier has an accuracy of 87.91%
which is 6% more than the accuracy of the WM based classifier. The same
pattern can also be observed based on the other metrics used for evaluation.
This may be due to the higher discriminability exhibited by GM regions
across AD and CN subjects44. In case of (GM+WM)-based classifiers, ac-
curacy is 89.26% which is 2% more than the accuracy obtained using GM
features alone. These results show that inclusion of WM features with GM
features improves classification accuracy. When GM+WM features are com-
bined with HV, accuracy further improves to 90.6%. This improvement in
accuracy can be attributed to the fact that HV has been shown to differ
significantly across AD and CN subjects3,6,7. Similarly, considering MMSE
and CDR scores in addition to GM+WM features resulted in classification
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accuracy of 91.27% (GM+WM+MMSE) and 93.28% (GM+WM+CDR), re-
spectively. But, considering HV together with clinical scores and GM+WM
features didn’t result in further improvements in classification accuracy. The
best classification accuracy of 94.63% was achieved by the classifier built
using GM+WM features and both clinical scores.
[insert table 3]
4.2. Performance Comparison with Recent Works
In this section, the performance of the SVM classifier built using various
combinations of features is compared with the performance reported by other
recent works in literature which include15,48,49 and50. Cuingnet et. al.15 is
considered for performance comparison as it employs the same training and
testing data sets as employed here for developing the SRPSO-SVM classifier.
The performance results of other methods used for comparison have been
reproduced from the corresponding publications. Table 4 presents the results
of comparison. Note that all the other works used for comparison have only
employed GM features for the purpose of classification.
It may be observed that the SVM classifier built in this work using GM
features has a sensitivity of 78% which is 3% lower than that reported by
Cuingnet et. al.15. This can be attributed to the differences in the ver-
sions of softwares used in pre-processing, resampling and masking. However,
the sensitivity of the SVM classifier improved when other features are in-
cluded in the analysis. Classifiers based on GM+WM, GM+WM+VoI and
GM+WM+clinical features resulted in sensitivities that are 4%, 7% and 10%
better than the performance reported by Cuingnet et. al. respectively.
In terms of classification accuracy, the performance of GM+WM features
based classifier was similar to the performance reported by Sun et. al.49
but it was 9% and 8% higher in comparison to results reported by Hu et.
al.48 and Zeng et. al.50. When VoI and clinical features were also included
in the analysis, the classifier performed 1% and 5% better than the perfor-
mance reported by Sun et. al.. Similar improvements can also be observed
when the sensitivity and specificity of the classifier built using GM+WM,
GM+WM+VoI and GM+WM+clinical features is compared to the perfor-
mance reported in other methods considered here for comparison. These
results clearly show that GM+WM features based classifiers result in similar
or better performance than the other methods used for comparison. Further,
inclusion of VoI and clinical features for building classifiers results in perfor-
mance that is better than the performance reported by other methods used
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for comparison.
[insert table 4]
4.3. Feature Selection Using SRPSO-SVM Classifier
In this section, the SRPSO-SVM classifier was used to select 10, 20,
30, 40 and 50 features in two different settings, namely feature selection
using GM and (GM+WM) regions. The effectiveness of the selected features
was evaluated based on the performance of the SVM classifiers trained only
using the selected features. The training/testing splits were same as those
employed in the previous section and classification accuracy (equation (10))
was used for performance evaluation.
Table 5 provides the classification accuracy of the SRPSO-SVM classi-
fier for different number of selected features. It can be clearly seen that the
training accuracy of both GM and (GM+WM) based classifiers increases sys-
tematically with an increase in the number of selected features. Further, the
training accuracy for both classifier types approaches 100% using 50 features
alone. Testing accuracy also increases in both cases with an increase in the
number of selected features. However, the performance of (GM+WM) classi-
fiers increased more rapidly in comparison to GM classifiers due to presence
of comparatively larger number of significant features. This clearly shows
that features extracted from WM regions are useful for building classifiers
with better performance.
It was also observed that, in all cases, (GM+WM) based classifiers per-
formed better than GM based classifiers in terms of classification accuracy
on testing samples. This can be clearly observed from figure 2 which shows a
plot of classification performance versus number of selected features for both
settings. Further, (GM+WM) based classifier using 50 features performed
better than the (GM+WM) classifiers using all features. This may be at-
tributed to the removal of less discriminative features in the feature selection
process which helps in improving the performance of SVM classifiers.
[insert table 5]
[insert figure 2]
4.4. Mapping Selected Features to Brain Regions
Features selected by the SRPSO-SVM classifier in the previous section
were used to identify the specific voxels from where these features were ex-
tracted during pre-processing. By mapping the identified voxels back to the
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brain areas, it was possible to identify the areas which exhibited discrimi-
native volumetric changes across AD subjects and CN individuals. For this
purpose, the identified voxels were mapped to a brain atlas using Automated
Anatomical Labelling (AAL). Figure 3 shows a plot of mapping the voxels
extracted from subset of 10 selected features to the corresponding brain ar-
eas in a glass brain. Similarly, all voxels from the subset of 20,30,40 and
50 selected voxels were extracted and mapped to the AAL template. This
amounted to total 150 voxels mapped to the template from all selected sub-
sets. The histogramof these selected voxels around brain regions is shown
in figure 4. This resulted in identification of brain areas already reported in
literature26,29,35–38,45 which includes areas like cerebellum47, temporal lobe46,
cingulate coretx32. In addition, our model identified some brain areas whose
involvement in AD is yet to be confirmed clinically, like parietal lobe26. The
features selected by SRPSO-SVM indicate that parietal lobe and some spe-
cific sub-regions within it like precuneus exhibit degeneration of brain tissue
in AD subjects. A future direction of clinical research could be validating
the extent of involvement of these brain regions in AD.
[insert figure 3]
[insert figure 4]
5. Conclusion
In this paper, a new approach has been developed for finding brain re-
gions which might contribute towards AD. This method utilizes SVM for
the problem of AD vs CN classification and the recently proposed SRPSO.
SRPSO was originally developed for continuous optimization problems and
here we extend it to the discrete problem of feature selection. The classifiers
used in this method employ Gray and White matter features extracted from
structural MRI images of AD subjects and CN individuals. Based on the
performance evaluation, it is shown that classifiers built using both GM and
WM features perform better than classifiers built using GM features alone.
On the basis of these results, we used SRPSO to select GM and WM features
that are important for the problem of AD vs CN classification. The perfor-
mance of classifiers built using 50 features selected by SRPSO was similar to
the performance of classifiers built using all GM and WM features. Mapping
the features selected by SRPSO to specific brain regions using AAL allowed
us to identify prospective brain areas that show degeneration in AD subjects.
In addition to brain areas that are known to be involved in AD (like cere-
15
bellum), this analysis also identified brain areas whose involvement in AD is
still debatable (like parietal lobe).
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6. Tables and Figures
Table 1: Demographic characteristics of AD and CN subjects of the ADNI dataset.
Group Diagnosis Number Age Gender MMSE
Training Set
CN 81 76.1±5.6 38M/43F 29.2±1.0
AD 69 75.8±7.5 34M/35F 23.3±1.9
Testing Set
CN 81 76.5±5.2 38M/43F 29.2±0.9
AD 68 76.2±7.2 33M/35F 23.2±2.1
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Table 2: The values for different parameters used in SRPSO for the simulations reported
in this paper.
Parameter Value
Total Iterations 1000
Swarm size 250
Acceleration coefficient, (c1) 1.49445
Acceleration coefficient, (c2) 1.49445
Initial inertia weight, (ωI) 1.05
Final inertia weight, (ωF ) 0.5
Rate of change inertia
weight, (ωv)
0.501
Velocity coefficient, (vc) 0.100625
Probability of velocity up-
date, (vp)
0.5
Table 3: Accuracy, sensitivity, selectivity, F1 score and precision of AD and CN based on
combination of volumetric and clinical data.
Features Acc Sen Spec F1
score
Prec
(%) (%) (%) (%) (%)
GM 87.91 77.94 96.29 85.48 94.64
WM 81.20 75 86.41 77.27 79.68
GM+WM 89.26 85.29 92.59 89.55 90.90
GM+WM+VoI 90.60 88.23 92.59 89.55 90.90
GM+WM+MMSE 91.27 88.23 93.82 90.22 92.30
GM+WM+MMSE+VoI 91.27 88.23 93.82 90.22 92.30
GM+WM+CDR 93.28 89.70 96.29 92.42 95.31
GM+WM+CDR+VoI 93.28 89.70 96.29 92.42 95.31
GM+WM+CDR+MMSE 94.63 91.17 97.53 93.93 96.87
GM+WM+CDR+MMSE+VoI 94.63 91.17 97.53 93.93 96.87
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Table 4: Comparison of classification accuracy with recent research works
Algorithm Feature Acc(%) Sen(%) Spec(%)
Cuingnet et. al.15 GM - 81 95
Hu et. al.48 GM 80.53 76.80 83.77
Sun et. al.49 GM 89.30 83.80 93.80
Zeng et. al.50 GM 81.25 - -
proposed work
GM 87.91 77.94 96.29
GM+WM 89.26 85.29 92.59
GM+WM+VoI 90.60 88.23 92.59
GM+WM+clinical 94.63 91.17 97.53
Table 5: Comparison of classification accuracy of training and testing data for GM and
(GM+WM)based features for feature size of 10,20,30,40,and 50
Feature Size
GM (GM+WM)
Training
Accuracy
(%)
Testing
Accuracy
(%)
Training
Accuracy
(%)
Testing
Accuracy
(%)
10 85.59 74.89 91.06 82.81
20 89.86 76.64 95.73 83.21
30 93.59 75.29 97.99 83.35
40 96 77.04 99.73 86.43
50 98.79 76.50 100 89.39
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Figure 1: A schematic diagram of the steps involved in preprocessing of T1-weighted MRI
images.
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Figure 2: Comparison of testing accuracy of classifier build on GM and (GM + WM)
based features.
Figure 3: Plot of selected subset of 10 features on glass brain. Gray square blocks in each
figure represent the selected regions.
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Figure 4: Frequency of occurrence of voxels in brain regions related to AD.
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